BIORIMA | Fraunhofer Institute for Molecular Biology and Applied Ecology

Fraunhofer Institute for Molecular Biology and Applied Ecology | IME

Fraunhofer Society (FhG): The research organization FhG undertakes applied research that drives economic development and serves the wider benefit of society. IME: The institute's activities cover two main areas: Molecular Biology and Applied Ecology. The project will be handled in the division Applied Ecology. The overall aim of this division is to determine and assess the risk posed by synthetic chemicals and natural substances, and to develop appropriate strategies for the protection of humans and environment.. Comprehensive simulation experiments in laboratory wastewater treatment plants, in model dumping site and in soil (laboratory and field) are performed. To study the fate specific devices (e.g. single particle analyses, FFF) are established. Furthermore, first experiments regarding the effect of (nano-) pharmaceuticals in soil are performed.

Fraunhofer Institute for Molecular Biology and Applied Ecology
Hansastraße 27C
80686 München
Germany

BIORIMA’s Final Public Event – Results, Reflections and Aspirations

A large audience of wide-ranging stakeholders logged on to take part in BIORIMA’s final public event, held on January 19th, 2022. Organised with polished efficiency by Lisa Bregoli and Stefania Melandri, Warrant Hub, the event comprised three distinct and engaging sessions: 1. Presentation of BIORIMA Final Results 2. Nanosafety projects response to real-world needs 3. NSC-community-activity “Brainstorming of future collaboration for nanobiomaterials risk assessment”

BIORIMA FINAL MEETING

The BIORIMA Project held its final meeting from 17th – 18th January, a large, well-attended gathering of project members from all partner organisations, the External Advisory Board, and Marcello Cacace, the Project Officer from the EC.

News from the BIORIMA Project

A safe and sustainable society and environment are the two pillars on which our future stands, and both have to be continuously supported and protected by transparent, long-sighted and science-based regulation that is shared by all actors involved. BIORIMA is contributing to these ongoing new regulatory needs by developing novel methodologies that help us to obtain the knowledge and tools to manage possible risks associated with emerging new materials, such as nano-biomaterials (NBM), when used in medical applications.

More News ...